-
Livonia Partners invests in Estonian healthcare company
We advised Livonia Partners, one of the leading private equity funds in the Baltics, on acquiring a majority stake in Medicum, one of Estonia’s largest healthcare companies. Founded in 1986, Medicum’s group of 450 employees provides general and specialised medical care across five locations in Tallinn, Harju County and Tartu. The involvement of Livonia Partners […]
-
Life Sciences & Healthcare newsletter, April 2025
In this newsletter, we discuss legal news which affects the pharmaceutical and pharmacy sector. The Commission’s proposal on the Critical Medicines Act will hopefully provide tools for member states to avoid supply chain issues in relation to critical medicines. Interpretations by the Court of Justice of the European Union assist market players to navigate in […]
-
Mehiläinen, Invalda INVL Group, Vinted and Elenger presented with awards for Baltic Deals of the Year 2025
Yesterday, the Baltic Deals of the Year were announced at the Baltic M&A and Private Equity Forum 2025 in Tallinn. The winners were Finnish-based Mehiläinen, Lithuania’s Vinted and Invalda INVL Group, and Estonia’s Elenger, part of the Infortar group. Award Winners 2025 The Baltic M&A Deal of the Year is Mehiläinen’s acquisition of InMedica. The […]
-
European Legal update: 04.03. – 17.03.2025.
Assistant lawyer Liis Pormeister compiled the material. Data and technology Regulation (EU) 2025/327 on the European Health Data Space published in OJ Published: 5 March 2025 Official publication has been made of Regulation (EU) 2025/327 of the European Parliament and of the Council of 11 February 2025 on the European Health Data Space. The regulation […]
-
Legal news that affects innovations in the Life Sciences & Healthcare sector
In this newsletter, we hope to draw your attention to legal news that, in one way or another, affects innovations in the life sciences and healthcare sector. Whether this relates to the early stages of product development (the Biotech and Biomanufacturing Hub) or questions related to the use of innovative products (the AI Act), innovation […]